A heart attack is hard on younger patients’ sex lifeWomen suffer more than men in the year after an acute MI, study finds Psoriasis and heart disease: ‘Major educational efforts’ neededCoronary arteries in just as bad a shape as those in type 2 diabetes patients Patient doing well on warfarin? Check again Stability is elusive for patients on long-term anticoagulation 2016 Canadian dyslipidemia guidelines Despite controversy, experts continue to recommend LDL-C targets for patients started on lipid-lowering therapy. Watch for drugs that can cause or worsen heart failure New AHA statement identifies potentially problematic drugs and provides tips for minimizing polypharmacy. Upsurge in ER visits for hypertension Inadequate patient information about interpreting home BP monitor readings may be a contributing factor. Hydroxyzine increases risk of QT prolongation/torsade de pointes in some patients Health Canada reduces maximum daily oral doses and issues new contraindications. Air pollution: Bad for the heart, bad for the fetus New studies provide more data on adverse effects of particulate matter Praxbind: first antidote for a direct-acting oral anticoagulant soon to be marketed Rapidly reverses the effects of dabigatran (Pradaxa) only. Primary prevention of cardiovascular events in older adults Statin therapy and blood pressure control have best evidence for primary prevention of cardiovascular events. First Previous 36 37 38 39 40 Next Last
